"NVIGEN...unveil its groundbreaking technology, NVIGEN X®-Precision Medicine Biomarker Profiling, at the San Antonio Breast Cancer Symposium from December 5 to 9."
"Nvigen...presented data last week at the San Antonio Breast Cancer Symposium showing that its Nvigen X Cancer Precision Profiling assay accurately monitors dynamic changes in circulating tumor DNA, or ctDNA...In a poster presented at SABCS, Nvigen showed performance metrics data of Nvigen X and a case study from an ongoing 150-person pilot study of the assay's performance in breast cancer patients."